ResearcherHokkaido UniversityNo recent work listed
Satoru Todo
Matched on ORCID iD 0000-0002-1277-4594; OpenAlex author ID A5043443062. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2011: 1 paper · 2012: 1 paper · 2013: 1 paper
Papers 3
- Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ. Co-author DOI 10.3727/096504014x14024160459249↗
- Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/etm.2012.518↗
- Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. Last author DOI 10.1097/mpa.0b013e318221bed8↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Takahiro Einama · 2 shared papers, 2011–2012 · strength 0.05
- Paper Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinom… DOI 10.3892/etm.2012.518↗
- Paper Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. DOI 10.1097/mpa.0b013e318221bed8↗
- Michitaka Ozaki · 2 shared papers, 2011–2013 · strength 0.05
- Paper Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, … DOI 10.3727/096504014x14024160459249↗
- Paper Co-expression of mesothelin and CA125 correlates with unfavorable patient outcome in pancreatic ductal adenocarcinoma. DOI 10.1097/mpa.0b013e318221bed8↗
- Junji Yamamoto · 1 shared paper, 2012 · strength 0.03
- Masanori Sato · 1 shared paper, 2013 · strength 0.03
- Akinobu Taketomi · 1 shared paper, 2013 · strength 0.03
- Hirofumi Kamachi · 1 shared paper, 2011 · strength 0.02
- Hiroshi Nishihara · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.